Track topics on Twitter Track topics that are important to you
The purpose of this research study is to examine the effect of cardiac denervation surgery, otherwise known as left cervicosympathectomy, on life threatening abnormal heart rhythms that can lead to sudden cardiac death.
Subjects will be asked to participate in this research trial if they have an indication and have been referred for ICD placement or have recently had an ICD placed, are at risk for abnormal heart rhythms, called ventricular tachycardias, and have already experienced at least one episode of ventricular tachycardia or fibrillation. The goal of this study is to determine whether left cervicosympathectomy can prevent these abnormal heart rhythms from occurring and therefore, prevent, ICD shocks, which are not only painful, but have been shown to reduce quality of life and/or lead to depression, particularly in the period immediately after the shock.
The purpose of this research study is to examine the effect of a procedure called left cervicothoracic sympathectomy which involves removal of part of the cervical stellate ganglia and thoracic ganglia of level 2 to 4. These ganglia house the left sided nerves that feed the heart and have been implicated in the occurrence of fast abnormal rhythms that cause defibrillator shocks and sudden death. Stimulation of these nerves has been shown to increase the incidence of sudden death and fast abnormal heart rhythms that lead to internal defibrillator shocks called ventricular tachycardia/ventricular fibrillation. Removal of the ganglia of these nerves in animal and human studies has been shown to decrease the incidence of life threatening abnormal rhythms and sudden death. The purpose of this study is to examine whether this procedure along with an internal defibrillator and current maximum medical therapy can reduce the incidence of these life threatening abnormal rhythms as compared to an internal defibrillator and medical therapy alone.
We are inviting patients to participate in this clinical trial whose personal physician has recommended that they have a internal defibrillator placed because they have already experienced one of these life threatening arrhythmias or because you already have an internal defibrillator that has shocked you at least once for the presence of these fast abnormal rhythms. You maybe randomized to receive the procedure and an internal defibrillator (if you don't have one already) plus maximum medical therapy or to receive the defibrillator and medical therapy. The procedure involves removal of part of the left sided ganglia of the nerves that feed the heart. This procedure takes less than 45 minutes and can be performed endoscopically.
We are asking 216 individuals (approximate age range 18-80 years) who are scheduled to have an internal defibrillator placed at UCLA and CARE center (though other centers are currently under consideration) to participate in this research trial but only half these individual will be randomized under the left cervicothoracic sympathectomy.
Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Sudden Cardiac Death
Left cervicothoracic sympathectomy, ICD and medical therapy only
Not yet recruiting
University of California, Los Angeles
Published on BioPortfolio: 2014-07-23T21:11:48-0400
To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differen...
A randomized controlled trial to test the potential safety and efficacy of LCSD in patients with heart failure due to non-ischemic and ischemic cardiomyopathy at the University of Cape Tow...
Sudden death is a major problem in industrially developed countries. Despite a decline in ischemic heart disease mortality and the progress has been made in resuscitation, treatment of sud...
The purpose of this study is to establish a quantitative LGE mass based scoring system (including LGE mass on cardiac magnetic resonance , clinical features, specific medical histories, et...
Sudden cardiac death continues to be a major contributor to mortality in patients with ischemic cardiomyopathy. While implantable defibrillators can prevent death from ventricular arrhythm...
Cardiac resynchronization therapy (CRT) for chronic heart failure with left ventricular systolic dysfunction (LVSD) consistently improves survival against optimal medical therapy alone. Limited data e...
We present the case of a spontaneously aborted sudden cardiac death related to an high-rate ventricular tachycardia in an healthy man with bileaflet mitral valve prolapse. An effective treatment of th...
Primary cardiac lymphomas represent approximately 1% to 2% of primary cardiac neoplasms and 5% of malignant cardiac neoplasms. Here we present a case of sudden unexpected death of a middle-aged male r...
We discuss a 46-year-old man with history of hypertension and inferior wall myocardial infarction and mild left ventricular dysfunction who presented with aborted sudden cardiac death due to episodes ...
Current guidelines recommendations, based on the results of primary sudden cardiac death prevention trials, use the left ventricular ejection fraction (LVEF) as a sole criterion for the indication of ...
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
Sympathectomy using chemicals (e.g., 6-hydroxydopamine or guanethidine) which selectively and reversibly destroy adrenergic nerve endings while leaving cholinergic nerve endings intact.
The research and development of ELECTRICAL EQUIPMENT AND SUPPLIES for such medical applications as diagnosis, therapy, research, anesthesia control, cardiac control, and surgery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
A condition caused by underdevelopment of the whole left half of the heart. It is characterized by hypoplasia of the left cardiac chambers (HEART ATRIUM; HEART VENTRICLE), the AORTA, the AORTIC VALVE, and the MITRAL VALVE. Severe symptoms appear in early infancy when DUCTUS ARTERIOSUS closes.
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...